Improving Hepatobiliary Imaging as a Physiologic Test with Superior Clinical Outcomes.

Cholecystokinin cholescintigraphy fatty meal gallbladder ejection fraction hepatobiliary imaging milk

Journal

World journal of nuclear medicine
ISSN: 1450-1147
Titre abrégé: World J Nucl Med
Pays: Germany
ID NLM: 101286955

Informations de publication

Date de publication:
Historique:
received: 21 02 2020
revised: 06 04 2020
accepted: 01 05 2020
entrez: 24 2 2021
pubmed: 25 2 2021
medline: 25 2 2021
Statut: epublish

Résumé

This study aims at prospectively evaluating the difference in the effect of cholecystokinin (CCK) and half-and-half milk (HHM) administered in the same patient on gallbladder contractility and correlation with clinical outcomes. Upon gallbladder visualization during standard hepatobiliary imaging, 0.02 μg/kg of CCK was injected over 3 min, and additional 30 min of dynamic imaging was obtained. Patients with gallbladder ejection fraction (GBEF) <35% after CCK were administered 8 oz of HHM followed by 30 min of imaging. The GBEF was recalculated. The number of patients whom GBEF changed from below 35% (abnormal) after CCK to above 35% (normal) after HHM was recorded. Follow-up of the clinical outcome at 6 months was performed. Fifty patients with abnormal GBEF were prospectively included. The average GBEF after CCK was 14.7% ± 8.5% and after HHM was 30.7% ± 20.8%. The average increase in GBEF with HHM was 16.0% ± 22.2%. The GBEF changed from abnormal to normal in 17 patients (34%). The remaining 33 patients remained abnormal. Clinical outcomes at 6 months were available in 47 patients. Cholecystectomy was performed in 60% of patients with abnormal GBEF with CCK and HHM with resolution or improvement of pain. Two of 16 patients (12%) with abnormal GBEF after CCK but normal after HHM had cholecystectomies with pain improvement, while 8 out of these patients (50%) were diagnosed and treated with other disorders and improved. Hepatobiliary imaging with HHM stimulation is a superior physiologic test which can lower the number of unnecessary cholecystectomies and misdiagnoses as functional cholecystitis.

Identifiants

pubmed: 33623504
doi: 10.4103/wjnm.WJNM_21_20
pii: WJNM-19-353
pmc: PMC7875040
doi:

Types de publication

Journal Article

Langues

eng

Pagination

353-358

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR003167
Pays : United States

Informations de copyright

Copyright: © 2020 World Journal of Nuclear Medicine.

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

Gut. 1987 Feb;28(2):137-41
pubmed: 3644773
J Nucl Med. 2010 Feb;51(2):277-81
pubmed: 20080900
Digestion. 2014;90(3):147-54
pubmed: 25278145
Am J Gastroenterol. 1990 Aug;85(8):986-90
pubmed: 2375327
J Nucl Med. 2003 Apr;44(4):499-504
pubmed: 12679391
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007086
pubmed: 19160318
Hepatobiliary Pancreat Dis Int. 2017 Apr;16(2):197-201
pubmed: 28381385
Am Surg. 2015 Jul;81(7):669-73
pubmed: 26140885
J Nucl Med. 2002 Dec;43(12):1603-10
pubmed: 12468508
Radiology. 1997 Jul;204(1):105-11
pubmed: 9205230
Am J Surg. 2015 Nov;210(5):963
pubmed: 26116320
Gastroenterology. 1991 Sep;101(3):786-93
pubmed: 1860640
J Nucl Med. 1991 Sep;32(9):1695-9
pubmed: 1880571
Clin Nucl Med. 2015 Oct;40(10):796-8
pubmed: 26222535
J Nucl Med. 2003 Aug;44(8):1263-6
pubmed: 12902416
Gastroenterology. 1981 Mar;80(3):482-90
pubmed: 7450441
Aliment Pharmacol Ther. 2003 Jul 15;18(2):167-74
pubmed: 12869076
J Gastrointest Surg. 2011 Feb;15(2):345-9
pubmed: 20824367
BMC Gastroenterol. 2015 Oct 15;15:136
pubmed: 26472428
Radiology. 1997 Jul;204(1):13-4
pubmed: 9205215

Auteurs

Isis W Gayed (IW)

Department of Diagnostic and Interventional Imaging, Nuclear Medicine Section, Houston, Texas, USA.

Lydia Dawood (L)

Department of Diagnostic and Interventional Imaging, Nuclear Medicine Section, Houston, Texas, USA.

Zhang Xu (Z)

Department of Internal Medicine, UTHealth McGovern Medical School, University of Texas, Houston, Texas, USA.

Grace Rizk (G)

Department of Diagnostic and Interventional Imaging, Nuclear Medicine Section, Houston, Texas, USA.

Andrew Dupont (A)

Department of Gastroenterology, UTHealth McGovern Medical School, University of Texas, Houston, Texas, USA.

Monica Atta (M)

Department of Diagnostic and Interventional Imaging, Nuclear Medicine Section, Houston, Texas, USA.

Emily K Robinson (EK)

Department of Surgery, UTHealth McGovern Medical School, University of Texas, Houston, Texas, USA.

Classifications MeSH